STOCKSCOPE

National Australia Bank (ASX: NAB) Reports $6.14 Billion Profit as Bad Debt Charges Surge 86%

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:3d ago
National Australia Bank (ASX: NAB) Reports $6.14 Billion Profit as Bad Debt Charges Surge 86%

National Australia Bank Limited (ASX: NAB) has reported $6.14 billion in annual statutory profit, but an 85.7% surge in credit impairment charges has exposed growing pressure beneath its expanding lending business.

Revenue increased 5.8% and underlying operating performance improved, yet adjusted cash earnings remained flat. The critical question is whether Australia's largest business lender can maintain profitability as economic conditions become more challenging.

Key Numbers

  • $6.14 billion: FY26 statutory net profit, down 9.1% from FY25.
  • $7.09 billion: Cash earnings excluding large notable items, broadly unchanged year-on-year.
  • $1.55 billion: Credit impairment charges, up 85.7% from $833 million.
  • 9.8%: Growth in Australian business lending balances during FY26.
  • 85 cents: Fully franked final dividend per share, bringing annual dividends to $1.70.

The Latest Development: Stronger Revenue Meets Rising Credit Costs

NAB's full-year results, released on 5 November 2026, reveal stronger operating income alongside deteriorating credit conditions.

Underlying profit excluding large notable items increased 6.9%, supported by lending growth, improved margins and cost discipline.

Net interest margin increased six basis points to 1.80%, reflecting stronger deposit returns and modest funding cost benefits.

However, credit impairment charges increased from $833 million to $1.55 billion, including $403 million in additional forward-looking provisions.

These provisions reflect expectations of more challenging economic conditions rather than losses already realised.

Reported cash earnings declined 13.4% to $6.14 billion, including a $949 million after-tax impact from changes to software capitalisation accounting.

Excluding this significant item, annual cash earnings remained essentially flat.

What Stands Out to Us

NAB's business banking franchise continues demonstrating its competitive strength.

Business and Private Banking delivered $3.69 billion in cash earnings, representing 10.7% annual growth, supported by stronger lending volumes, improved margins and higher fee income.

However, Corporate and Institutional Banking earnings declined 6.1%, partly reflecting increased credit impairment charges.

This highlights an important vulnerability: expanding lending balances can strengthen revenue while simultaneously increasing exposure to borrowers experiencing financial difficulties.

NAB's balance sheet remains resilient, with a Common Equity Tier 1 capital ratio of 11.87% at 30 September 2026.

Management expects this ratio to reach approximately 12.07% following the anticipated impact of its discounted final dividend reinvestment plan.

For valuation, earnings quality remains central. NAB reported an 11.4% cash return on equity excluding large notable items, making sustained profitability and capital efficiency important measures of whether its market valuation is justified.

What the Company Is Doing Now

NAB is accelerating efforts to simplify operations, modernise technology and strengthen customer relationships.

The bank delivered $463 million in productivity benefits during FY26 while maintaining investment expenditure of approximately $1.8 billion.

It is also progressing plans to eliminate up to 2,500 internal positions during FY27, with an anticipated $300 million pre-tax restructuring charge.

Management expects underlying cost growth below 3% in FY27, excluding specified restructuring and software accounting impacts.

Alongside these changes, NAB continues prioritising business lending, deposits and direct mortgage distribution.

Australian home lending drawdowns through proprietary channels increased to 50% during FY26, compared with 41% in FY25.

Insight: Can NAB Protect Profitability as Credit Risks Increase?

We think NAB's core business remains fundamentally strong, supported by its established business banking franchise, improving margins and substantial capital buffers. However, the 85.7% increase in credit impairment charges is more consequential than headline revenue growth suggests. Stronger lending volumes offer limited benefit if additional credit losses absorb incremental earnings. The restructuring could improve efficiency, but its financial contribution remains unproven. Our assessment is cautiously constructive on the underlying franchise, although sustained earnings improvement will require credit conditions to stabilise alongside measurable cost savings.

What Happens Next?

NAB's next challenge is translating stronger operating performance into improved cash earnings.

Management forecasts Australian economic growth slowing to 1.0% during calendar 2027, potentially increasing pressure on households and businesses.

The most important indicators will be credit impairment charges, net interest margins and progress towards the FY27 underlying cost growth target.

Evidence of stabilising credit quality, combined with continued business lending growth, would strengthen NAB's earnings outlook.

For shareholders, the central issue is no longer whether NAB can expand its lending portfolio. It is whether that growth can generate sustainable profitability despite rising credit risks.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...